• 1
    Linsley, P. S. and Ledbetter, J. A., The role of the CD28 receptor during T cell responses to antigen. Annu. Rev. Immunol. 1993. 11: 191212.
  • 2
    Hutloff, A., Dittrich, A. M., Beier, K. C., Eljaschewitsch, B., Kraft, R., Anagnostopoulos, I. and Kroczek, R. A., ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28. Nature 1999. 397: 263266.
  • 3
    Yoshinaga, S. K., Whoriskey, J. S., Khare, S. D., Sarmiento, U., Guo, J., Horan, T., Shih, G. et al., T-cell co-stimulation through B7RP-1 and ICOS. Nature 1999. 402: 827832.
  • 4
    McAdam, A. J., Greenwald, R. J., Levin, M. A., Chernova, T., Malenkovich, N., Ling, V., Freeman, G. J. et al., ICOS is critical for CD40-mediated antibody class switching. Nature 2001. 409: 102105.
  • 5
    Tafuri, A., Shahinian, A., Bladt, F., Yoshinaga, S. K., Jordana, M., Wakeham, A., Boucher, L. M. et al., ICOS is essential for effective T-helper-cell responses. Nature 2001. 409: 105109.
  • 6
    Gonzalo, J. A., Tian, J., Delaney, T., Corcoran, J., Rottman, J. B., Lora, J., Al-garawi, A. et al., ICOS is critical for T helper cell-mediated lung mucosal inflammatory responses. Nat. Immunol. 2001. 2: 597604.
  • 7
    Grimbacher, B., Hutloff, A., Schlesier, M., Glocker, E., Warnatz, K., Drager, R., Eibel, H. et al., Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency. Nat. Immunol. 2003. 4: 261268.
  • 8
    Yu, D., Tan, A. H., Hu, X., Athanasopoulos, V., Simpson, N., Silva, D. G., Hutloff, A. et al., Roquin represses autoimmunity by limiting inducible T-cell co-stimulator messenger RNA. Nature 2007. 450: 299303.
  • 9
    Ogawa, S., Nagamatsu, G., Watanabe, M., Watanabe, S., Hayashi, T., Horita, S., Nitta, K. et al., Opposing effects of anti-activation-inducible lymphocyte-immunomodulatory molecule/inducible costimulator antibody on the development of acute versus chronic graft-versus-host disease. J. Immunol. 2001. 167: 57415748.
  • 10
    Watanabe, S., Ogawa, S., Hara, Y., Tanabe, K., Toma, H. and Abe, R., Expression level of costimulatory receptor ICOS is critical for determining the polarization of helper T cell function. Transpl. Immunol. 2006. 15: 255263.
  • 11
    Shilling, R. A., Pinto, J. M., Decker, D. C., Schneider, D. H., Bandukwala, H. S., Schneider, J. R., Camoretti-Mercado, B. et al., Cutting edge: polymorphisms in the ICOS promoter region are associated with allergic sensitization and Th2 cytokine production. J. Immunol. 2005. 175: 20612065.
  • 12
    Okamoto, T., Saito, S., Yamanaka, H., Tomatsu, T., Kamatani, N., Ogiuchi, H., Uchiyama, T. et al., Expression and function of the co-stimulator H4/ICOS on activated T cells of patients with rheumatoid arthritis. J. Rheumatol. 2003. 30: 11571163.
  • 13
    Yang, J. H., Zhang, J., Cai, Q., Zhao, D. B., Wang, J., Guo, P. E., Liu, L. et al., Expression and function of inducible costimulator on peripheral blood T cells in patients with systemic lupus erythematosus. Rheumatology (Oxford) 2005. 44: 12451254.
  • 14
    Tan, A. H., Wong, S. C. and Lam, K. P., Regulation of mouse inducible costimulator (ICOS) expression by Fyn-NFATc2 and ERK signaling in T cells. J. Biol. Chem. 2006. 281: 2866628678.
  • 15
    Tan, A. H., Goh, S. Y., Wong, S. C. and Lam, K. P., T helper cell-specific regulation of inducible costimulator expression via distinct mechanisms mediated by T-bet and GATA-3. J. Biol. Chem. 2008. 283: 128136.
  • 16
    Wagner, E. F. and Eferl, R., Fos/AP-1 proteins in bone and the immune system. Immunol. Rev. 2005. 208: 126140.
  • 17
    Yagi, J., Dianzani, U., Kato, H., Okamoto, T., Katsurada, T., Buonfiglio, D., Miyoshi-Akiyama, T. et al., Identification of a new type of invariant Vα14+T cells and responsiveness to a superantigen, Yersinia pseudotuberculosis-derived mitogen. J. Immunol. 1999. 163: 30833091.
  • 18
    Coyle, A. J., Lehar, S., Lloyd, C., Tian, J., Delaney, T., Manning, S., Nguyen, T. et al., The CD28-related molecule ICOS is required for effective T cell-dependent immune responses. Immunity 2000. 13: 95105.
  • 19
    Watanabe, M., Hara, Y., Tanabe, K., Toma, H. and Abe, R., A distinct role for ICOS-mediated co-stimulatory signaling in CD4+ and CD8+T cell subsets. Int. Immunol. 2005. 17: 269278.
  • 20
    Okada, S., Obata, S., Hatano, M. and Tokuhisa, T., Dominant-negative effect of the c-fos family gene products on inducible NO synthase expression in macrophages. Int. Immunol. 2003. 15: 1275-1282.
  • 21
    Dong, C., Davis, R. J. and Flavell, R. A., MAP kinases in the immune response. Annu. Rev. Immunol. 2002. 20: 5572.
  • 22
    Rincon, M. and Flavell, R. A., AP-1 transcriptional activity requires both T-cell receptor-mediated and co-stimulatory signals in primary T lymphocytes. EMBO J. 1994. 13: 43704381.
  • 23
    Isakov, N. and Altman, A., Protein kinase CΘ in T cell activation. Annu. Rev. Immunol. 2002. 20: 761794.
  • 24
    McAdam, A. J., Chang, T. T., Lumelsky, A. E., Greenfield, E. A., Boussiotis, V. A., Duke-Cohan, J. S., Chernova, T. et al., Mouse inducible costimulatory molecule (ICOS) expression is enhanced by CD28 costimulation and regulates differentiation of CD4+T cells. J. Immunol. 2000. 165: 50355040.
  • 25
    Rao, A., Luo, C. and Hogan, P. G., Transcription factors of the NFAT family: regulation and function. Annu. Rev. Immunol. 1997. 15: 707747.
  • 26
    Harada, Y., Ohgai, D., Watanabe, R., Okano, K., Koiwai, O., Tanabe, K., Toma, H. et al., A single amino acid alteration in cytoplasmic domain determines IL-2 promoter activation by ligation of CD28 but not inducible costimulator (ICOS). J. Exp. Med. 2003. 197: 257262.
  • 27
    Yagi, J., Arimura, Y., Dianzani, U., Uede, T., Okamoto, T. and Uchiyama, T., Regulatory roles of IL-2 and IL-4 in H4/inducible costimulator expression on activated CD4+T cells during Th cell development. J. Immunol. 2003. 171: 783794.
  • 28
    Wassink, L., Vieira, P. L., Smits, H. H., Kingsbury, G. A., Coyle, A. J., Kapsenberg, M. L. and Wierenga, E. A., ICOS expression by activated human Th cells is enhanced by IL-12 and IL-23: increased ICOS expression enhances the effector function of both Th1 and Th2 cells. J. Immunol. 2004. 173: 17791786.
  • 29
    Masse, G. X., Corcuff, E., Strick-Marchand, H., Guy-Grand, D., Tafuri-Bladt, A., Albert, M. L., Lantz, O. et al., cγ cytokines condition the progressive differentiation of CD4+T cells. Proc. Natl. Acad. Sci. USA 2007. 104: 1544215447.
  • 30
    Liao, W., Lin, J. X. and Leonard, W. J., IL-2 family cytokines: new insights into the complex roles of IL-2 as a broad regulator of T helper cell differentiation. Curr. Opin. Immunol. 2011. 23: 598604.
  • 31
    King, C., Tangye, S. G. and Mackay, C. R., T follicular helper (TFH) cells in normal and dysregulated immune responses. Annu. Rev. Immunol. 2008. 26: 741766.
  • 32
    Korn, T., Bettelli, E., Oukka, M. and Kuchroo, V. K., IL-17 and Th17 cells. Annu. Rev. Immunol. 2009. 27: 485517.
  • 33
    Nurieva, R. I., Chung, Y., Hwang, D., Yang, X. O., Kang, H. S., Ma, L., Wang, Y. H. et al., Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages. Immunity 2008. 29: 138149.
  • 34
    Bauquet, A. T., Jin, H., Paterson, A. M., Mitsdoerffer, M., Ho, I. C., Sharpe, A. H. and Kuchroo, V. K., The costimulatory molecule ICOS regulates the expression of c-Maf and IL-21 in the development of follicular T helper cells and TH-17 cells. Nat. Immunol. 2008. 10: 167175.
  • 35
    Watanabe, M., Watanabe, S., Hara, Y., Harada, Y., Kubo, M., Tanabe, K., Toma, H. et al., ICOS-mediated costimulation on Th2 differentiation is achieved by the enhancement of IL-4 receptor-mediated signaling. J. Immunol. 2005. 174: 19891996.
  • 36
    Edgar, R., Domrachev, M. and Lash, A. E., Gene expression omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 2002. 30: 207210.
  • 37
    Morita, S., Kojima, T. and Kitamura, T., Plat-E: an efficient and stable system for transient packaging of retroviruses. Gene Ther. 2000. 7: 10631066.
  • 38
    Sreeramaneni, R., Chaudhry, A., McMahon, M., Sherr, C. J. and Inoue, K., Ras-Raf-Arf signaling critically depends on the Dmp1 transcription factor. Mol. Cell. Biol. 2005. 25: 220232.
  • 39
    Koga, K., Takaesu, G., Yoshida, R., Nakaya, M., Kobayashi, T., Kinjyo, I. and Yoshimura, A., Cyclic adenosine monophosphate suppresses the transcription of proinflammatory cytokines via the phosphorylated c-Fos protein. Immunity 2009. 30: 372383.
  • 40
    Zhang, G., Fahmy, R. G., diGirolamo, N. and Khachigian, L. M., JUN siRNA regulates matrix metalloproteinase-2 expression, microvascular endothelial growth and retinal neovascularisation. J. Cell. Sci. 2006. 119: 32193226.
  • 41
    Gurzov, E. N., Bakiri, L., Alfaro, J. M., Wagner, E. F. and Izquierdo, M., Targeting c-Jun and JunB proteins as potential anticancer cell therapy. Oncogene 2008. 27: 641652.
  • 42
    Takata, Y., Chu, V., Collins, A. R., Lyon, C. J., Wang, W., Blaschke, F., Bruemmer, D. et al., Transcriptional repression of ATP-binding cassette transporter A1 gene in macrophages: a novel atherosclerotic effect of angiotensin II. Circ. Res. 2005. 97: e8896.
  • 43
    Yamashita, M., Kuwahara, M., Suzuki, A., Hirahara, K., Shinnaksu, R., Hosokawa, H., Hasegawa, A. et al., Bmi1 regulates memory CD4 T cell survival via repression of the Noxa gene. J. Exp. Med. 2008. 205: 11091120.